Evaluation of the effect of multiple administrations of gadopentetate dimeglumine or gadoterate meglumine on brain T1-weighted hyperintensity in pediatric patients

• Published in: Pediatric radiology Vol. 51; no. 13; pp. 2568 - 2580
• Main Authors: Towbin, Alexander J., Zhang, Bin, Dillman, Jonathan R.
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.12.2021; Springer Nature B.V
• Subjects: Brain; Brain - diagnostic imaging; Cerebellar Nuclei; Child; Children & youth; Contrast Media; Drug dosages; Electronic health records; Field strength; Gadolinium; Gadolinium DTPA; Gadopentetate dimeglumine; Hospitals; Humans; Imaging; Infant; Magnetic Resonance Imaging; Medical records; Medicine; Medicine & Public Health; Meglumine; Neuroimaging; Neuroradiology; Nuclear Medicine; Oncology; Organometallic Compounds; Original Article; Patients; Pediatrics; Radiology; Retrospective Studies; Ultrasound; Brain; Gadolinium; Children; Magnetic resonance imaging; Gadolinium deposition; Pediatric radiology
• ISSN: 0301-0449; 1432-1998
• DOI: 10.1007/s00247-021-05134-4

Background Repeated administrations of linear gadolinium-based contrast media (GBCM) are associated with T1-weighted (T1-W) signal intensity change in brain structures. Objective The purpose of this study was to compare different brain structures in children after unconfounded, repeated administrations of either a macrocyclic or linear GBCM. Materials and methods We performed a retrospective cohort study, identifying subjects with ≥5 unconfounded administrations of gadoterate meglumine. We matched subjects with repeated administrations of gadopentetate dimeglumine to the gadoterate meglumine arm based on the number of unconfounded GBCM administrations. Two reviewers drew regions of interest on 27 structures in and around the brain. We recorded demographic, modality and study parameters and evaluated them to determine whether they were associated with T1-W signal intensity (SI) changes. Linear mixed effects models evaluated the relationships between the number of GBCM doses and T1-W SI ratio. Finally, we identified differences in the rate of T1-W SI ratio change among individuals using a linear mixed effects model with random slope. Results We included a total of 52 patients (age range at first MRI: 6.0 months to 17.1 years), 26 in each arm. We detected a significant change in the T1-W SI ratio with repeated administrations of GBCM in one location in the gadoterate meglumine arm and in four locations in the gadopentetate dimeglumine arm. Patient gender and age were not associated with T1-W SI change. Modality vendor, imaging sequence and field strength were variably associated with a systematic difference in the ability to detect a T1-W SI change. Finally, linear mixed effects model with random slope showed that there were individual differences in the slope of SI change at various structures among individuals for both arms. This effect was present in more brain structures in the gadopentetate dimeglumine arm (14 vs. 8). Conclusion There is a significant change in the T1-W SI ratio over time in multiple brain structures after repeated gadopentetate dimeglumine administrations. This effect was only seen in one ratio after repeated administrations of gadoterate meglumine. There are individual differences in the rate of change of SI ratios over time after repeated administration of gadopentetate dimeglumine and gadoterate meglumine, suggesting that individual differences are present.